-
ROSSLARE EUROPORT TARGETS HEALTH & SAFETY WITH CAMERA TELEMATICS PARTNERSHIP - 2 days ago
-
Landmark Study Reveals Wearable Robotics Significantly Boost Safety and Efficiency in Industrial Environments - July 24, 2024
-
Visku Tackle The Retail Seasonality Challenge One Pallet At A Time - July 22, 2024
-
KAMMAC AND BERGEN LOGISTICS STRENGTHEN FASHION & LIFESTYLE SERVICES IN THE UK - July 19, 2024
-
TENTBOX EXTENDS PARTNERSHIP WITH ARROWXL TO SUPPORT INCREASING DEMAND - July 17, 2024
-
The Perfume Shop improves customer journeys while driving profitability in partnership with Scurri - July 17, 2024
-
ZEROMISSION SECURES £2.3M ($3M) INVESTMENT TO ACCELERATE ELECTRIC FLEETS - July 16, 2024
-
BCMPA CELEBRATES SUCCESS OF 2024 CONFERENCE - July 15, 2024
-
Best of the Best: Jungheinrich Celebrates Triple International Award Win - July 12, 2024
-
GOPLASTICPALLETS.COM CALLS ON NEW CHANCELLOR RACHEL REEVES TO CONSIDER PLASTIC PACKAGING TAX REFORM - July 10, 2024
Passive or Active? Supply chain leaders compare key pharmaceutical cold chain technologies in latest white paper
The vital role that temperature-controlled packaging plays in transporting pharmaceuticals around the world has been highlighted in a new white paper from Tower Cold Chain, with the aim of helping stakeholders find the right solution for their needs.
Compounded by the demands of the COVID-19 pandemic, the white paper provides practical advice on the various options available, with insight delivered by seven leading industry experts from across the supply chain. These include senior decision makers from Johnson & Johnson, DHL and LOT Polish Airlines, who deliver an unbiased guide that is ideal for specifiers in pharmaceuticals, 3PL and air freight looking to make informed choices.
Free to download from the Tower website, the white paper – titled ‘Passive v Active in a globally disrupted age’ – collates the key findings of a 90-minute webinar organised by Tower in late 2021. Amongst the topics covered are the rapid changes affecting the industry; the new challenges that are arising in delivering vaccines to remote areas; and the considerations that must be made in selecting the optimum container type for the task.
At the heart of the publication is an assessment of the relative merits of Active, Passive and Hybrid temperature-controlled packaging solutions with detailed insight on their use across the global pharmaceutical supply chain.
In an unbiased review of the technologies the white paper identifies a place for all types of temperature-controlled solutions within the market.
“In some circumstances, active methods are ideal. In others, passive is the only sensible choice to de-risk the shipment,” explains Kevin Doran, Global Head of Supply Chain at Tower Cold Chain.
“When it comes to patient care and the effective delivery of critical pharmaceuticals there’s no benefit in being partisan. We felt it was vital that decision makers can get a balanced view, which is why this white paper brings together a wide range of voices to survey the whole landscape and identify the scenarios for the best use of each technology.
“We’re grateful to all of the experts who gave their time and provide such a rich source of insight and information – and we look forward to sharing it with others.”
The white paper can be downloaded here.